Back to top

Analyst Blog

On Jan 24, 2013, we upgraded our recommendation on chemical giant DuPont (DD - Analyst Report) to Neutral based on its better-than-expected fourth-quarter 2012 results and improved prospects.

Why the Upgrade?

DuPont, on Jan 22, posted adjusted earnings from continuing operations of 11 cents per share for the fourth quarter, beating the Zacks Consensus Estimate by a couple of cents. Net sales were essentially flat year over year at $7,325 million but exceeded the Zacks Consensus Estimate of $7,253 million.

Following the release of the forecast-topping fourth quarter results, the Zacks Consensus Estimate for 2013 rose 3.7% to $3.92 per share. Moreover, the Zacks Consensus Estimate for 2014 moved up by 3.8% to $4.35 per share.

DuPont, which carries a Zacks Rank #2 (Buy), is witnessing strength in its agriculture and food businesses. Despite unfavorable currency exchange swings, the Agriculture segment delivered healthy sales in the fourth quarter boosted by higher volume and strong performance of the crop protection business. The company expects continued strong growth in crop protection in 2013 to be driven by new products.

Moreover, DuPont should continue to benefit from the synergies of Danisco acquisition. The acquisition contributed to the growth across its Industrial Biosciences and Nutrition & Health divisions in the fourth quarter.

DuPont also has a healthy balance sheet and remains committed to boost shareholder returns. It will also continue to benefit from its aggressive restructuring actions.

That said, we also account for the weakness across titanium dioxide and photovoltaic markets. The company is also exposed to raw material cost inflation and currency headwinds.

Other Stocks to Consider

In addition to DuPont, other stocks in the chemical industry that are currently performing well include Arkema S.A. (ARKAY), BASF SE (BASFY) and Air Products (APD - Analyst Report). While both Arkema and BASF retain a Zacks Rank #1 (Strong Buy), Air Products holds a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 2.99 +2.75%
CHIPOTLE ME… CMG 689.54 +1.64%
CHINA BIOLO… CBPO 46.81 +1.62%
INTEL CP INTC 34.87 +1.06%
GILEAD SCIE… GILD 101.77 +0.97%